January 2025, DEA Administrative Law Judge John Mulrooney abruptly canceled the docketed hearing scheduled to begin on January 21, 2025. The hearing was intended to hear from various stakeholders' views amidst a federal government turnover which may have a different view than the previous administration. ALJ Mulrooney stated, "The strangeness of this unsupported approach is amplified by the fact that the appointment of a new DEA Administrator by a different political party is imminent.” Thus, the decision to reschedule marijuana from Schedule I (no medicinal purpose and high potential for abuse) to Schedule III (pharmaceutical purpose and moderate potential for abuse) will reside with the new DEA Administrator, upon Senate confirmation. It remains to be seen how the federal reclassification will impact the pharmaceutical distribution of marijuana.
Blockchain Technology for Agriculture: Applications and Rationale
Revolutionizing Blockchain Agriculture: A Sustainable Future with Eden Green
An article published by Harbor America dated February 28, 2022, discussing basic regulatory compliance authority and requirements for the agricultural industry
BCAGS is showcased by Amazon Web Services (AWS) on their website
SUPREME COURT OF THE UNITED STATES STANDING AKIMBO, LLC, ET AL., v. UNITED STATES ON PETITION FOR WRIT OF CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR THE TENTH CIRCUIT No. 20–645. Decided June 28, 2021
Oregon, Washington and California pass legislation authorizing interstate commerce of cannabis in defiance of the US Constitution's Commerce Clause and the US Supreme Court
Current FDA regulation - Numerous entities have requested cannabis be placed in schedule III of the Controlled Substance Act
Drug schedules and the general guidelines for each schedule as defined by the Drug Enforcement Administration
H.R.5601 — 118th Congress (2023-2024)
This bill decriminalizes marijuana.
Specifically, it removes marijuana from the list of scheduled substances under the Controlled Substances Act and eliminates criminal penalties for an individual who manufactures, distributes, or possesses marijuana
H.R.610 — 118th Congress (2023-2024
This bill moves marijuana to a lower schedule of the Controlled Substances Act.
Specifically, it directs the Drug Enforcement Administration to transfer marijuana from schedule I to schedule III. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; that has no currently accepted medical use; and that is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. A schedule III controlled substance is a drug, substance, or chemical that has less potential for abuse than a schedule I or II substance; that has a currently accepted medical use; and that has low or moderate risk of dependence if abused.
Financial Crimes Enforcement Network (FINCEN) is a government tracking system for financial transactions throughout the United States. Potential crimes are highlighted in the reporting and all law enforcement including but not limited to, the Drug Enforcement Administration (DEA), Federal Bureau of Investigations (FBI), Homeland Security Investigations (HSI), Secret Service, and State and local law enforcement have access to it. Ultimately, this means that the DEA can and does track proceeds from cannabis which violate the Controlled Substance Act/federal law. Under Title 21 (the Controlled Substance Act), all proceeds in violation of Title 21 can be seized. Due diligence of banks is an institutionalized procedure (at a significant cost to the user)to mitigate the risk of seizure and tracked through FINCEN. It does not protect recreational or medicinal cannabis sales, but does protect hemp/CBD derived from cannabis if it can be proven that it does not exceed .3% THC. The BCAGS agricultural block chain provides the due diligence for recreational and medicinal cannabis as part of the service (no additional bank fees would be required) and offers protections in the hemp/CBD market.
9 Facts about Americans and Marijuana
The use and possession of marijuana is illegal under U.S. federal law, but about three-quarters of states have legalized the drug for medical or recreational purposes. The changing legal landscape has coincided with a decades-long rise in public support for legalization, which a majority of Americans now favor.
Here are nine facts about Americans’ views of and experiences with marijuana, based on Pew Research Center surveys and other sources.
Sign up to hear from us about specials, news, and events.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.